Advertisement

Topics

Agilis Biotherapeutics, Gene Therapy Research Institution Enter Strategic Partnership

16:00 EDT 4 Aug 2017 | Drug Discovery Development

Agilis and GTRI will also collaborate to expedite the development, approval and commercialization of select gene therapies in specific CNS diseases.
Contributed Author: 
Agilis Biotherapeutics

Original Article: Agilis Biotherapeutics, Gene Therapy Research Institution Enter Strategic Partnership

NEXT ARTICLE

More From BioPortfolio on "Agilis Biotherapeutics, Gene Therapy Research Institution Enter Strategic Partnership"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...